Drug recall · March 30, 2022
REVITADERM WOUND CARE GEL recall
Why: Microbial Contamination of Non-sterile Product; FDA analysis found the product to be contaminated with Bacillus cereus.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
REVITADERM WOUND CARE GEL, (Benzalkonium Chloride in a gel containing transforming growth factor-b), 0.1%, packaged in 29.6 mL (1.0 FL OZ) bottles (NDC 63347-120-02) and 88.7 mL (3.0 FL OZ) tubes (NDC 63347-120-01), Blaine Labs Inc., Santa Fe Springs, CA 90670
- Lots / codes
Lot/Batch #: BL 2844, Expiration date 2/19/2023
- Quantity
- 1119 (1 oz.) bottles/ 772 (3 oz.) tubes
- Company
- Blaine Labs Inc, Santa Fe Springs, CA
- Distribution
- Nationwide in 17 States to 45 doctors.
- Initiated
- January 25, 2022 · Voluntary: Firm initiated
- Classified
- March 18, 2022
- Reported
- March 30, 2022
- Ended
- August 1, 2022
- How notified
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Benzalkonium
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.